Complete remission and virologic response to combined chemoimmunotherapy (R-CVP) followed by rituximab maintenance in HIV-negative, HHV-8 positive patient with multicentric Castleman disease.
Fragasso
Alberto
A
Mannarella
Clara
C
Ciancio
Angela
A
Calvario
Agata
A
Scarasciulli
Maria Luisa
ML
D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005871:Castleman Disease / Q000188:drug therapy* / Q000821:virology; D006566:Herpesviridae Infections; D019288:Herpesvirus 8, Human; D006801:Humans; D008297:Male; D012074:Remission Induction; D000069283:Rituximab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab